Correlation Between Editas Medicine and MediciNova

Can any of the company-specific risk be diversified away by investing in both Editas Medicine and MediciNova at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Editas Medicine and MediciNova into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Editas Medicine and MediciNova, you can compare the effects of market volatilities on Editas Medicine and MediciNova and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Editas Medicine with a short position of MediciNova. Check out your portfolio center. Please also check ongoing floating volatility patterns of Editas Medicine and MediciNova.

Diversification Opportunities for Editas Medicine and MediciNova

-0.23

Correlation Coefficient

Editas Medicine  MediciNova

Very good diversification

The 3 months correlation between Editas and MediciNova is -0.23. Overlapping area represents the amount of risk that can be diversified away by holding Editas Medicine and MediciNova in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on MediciNova and Editas Medicine is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Editas Medicine are associated (or correlated) with MediciNova. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of MediciNova has no effect on the direction of Editas Medicine i.e., Editas Medicine and MediciNova go up and down completely randomly.

Pair Corralation between Editas Medicine and MediciNova

Given the investment horizon of 90 days Editas Medicine is expected to generate 4.71 times more return on investment than MediciNova. However, Editas Medicine is 4.71 times more volatile than MediciNova. It trades about 0.06 of its potential returns per unit of risk. MediciNova is currently generating about -0.18 per unit of risk. If you would invest  121.00  in Editas Medicine on December 27, 2024 and sell it today you would earn a total of  6.00  from holding Editas Medicine or generate 4.96% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Editas Medicine  vs.  MediciNova

Editas Medicine

Risk-Adjusted Performance

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Editas Medicine are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively unfluctuating forward indicators, Editas Medicine unveiled solid returns over the last few months and may actually be approaching a breakup point.

MediciNova

Risk-Adjusted Performance

Very Weak

Over the last 90 days MediciNova has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Stock's basic indicators remain fairly stable which may send shares a bit higher in April 2025. The latest fuss may also be a sign of long-term up-swing for the venture sophisticated investors.

Pair Trading with Editas Medicine and MediciNova

The main advantage of trading using opposite Editas Medicine and MediciNova positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Editas Medicine position performs unexpectedly, MediciNova can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in MediciNova will offset losses from the drop in MediciNova's long position.

The idea behind Editas Medicine and MediciNova pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.